Herring (Clupea harengus) supplemented diet influence risk factors for CVD in overweight subjects
Artikel i vetenskaplig tidskrift, 2007

Objective: To assess the effect of a 4-week herring diet compared to a reference diet on biomarkers for cardiovascular disease in obese subjects. Design: Randomized crossover trial. Setting: Department of Internal Medicine, Sahlgrenska University Hospital. Subjects: Fifteen healthy obese men and women ( age 24-70 years) included, 13 completed. Intervention: Subjects were randomly assigned to four weeks of herring diet ( 150 g baked herring fillets/day 5, days/week) or reference diet ( pork and chicken fillets) and switched diets after 2 weeks washout. P-total cholesterol, p-TAG, p-HDL, p-HDL(2), p-HDL(3), p-LDL, p-apolipoprotein A, p-apolipoprotein B, p-Lipoprotein ( a), p-fibrinogen, p-C- reactive protein and p-antioxidative capacity were analysed at 0,2,4,6,8 and 10 weeks. Results: P-HDL was significantly higher after the herring diet period compared to after the reference diet period; 1.22 vs 1.13 mmol/l ( P = 0.036). There was a small, but not statistically significant, decrease in TAG but no effect on other biomarkers. TEAC and FRAP, but not ORAC-values, indicated that plasma antioxidants may have been reduced. CRP tended to be lower after the herring diet compared to after the reference diet. Conclusions: Consumption of oven-baked herring ( 150g/day, 5 days/week) for 4 weeks, compared to consumption of pork and chicken fillets, significantly increased p-HDL. Patients with insulin resistance and obesity, who commonly have low HDL, may therefore benefit from addition of herring to the diet.

Författare

Helen Lindqvist

Chalmers, Kemi- och bioteknik, Livsvetenskaper

Anna-Maria Langkilde

Sahlgrenska universitetssjukhuset

Ingrid Undeland

Chalmers, Kemi- och bioteknik, Livsvetenskaper

Therese Rådendal

Chalmers

Ann-Sofie Sandberg

Chalmers, Kemi- och bioteknik, Livsvetenskaper

European Journal of Clinical Nutrition

0954-3007 (ISSN) 14765640 (eISSN)

Vol. 61 9 1106-1113

Ämneskategorier

Farmaceutisk vetenskap

DOI

10.1038/sj.ejcn.1602630

PubMed

17268414

Mer information

Senast uppdaterat

2018-09-10